文献速递心力衰竭与心肌病冠心病

肌钙蛋白阳性COVID-19康复患者心肌损伤模式的CMR评估

Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance.
PubMed 文献 · Eur Heart J · 2021-01-01

本研究对148例重症COVID-19且肌钙蛋白升高的康复患者行恢复期多参数心脏磁共振检查,中位68天。89%左室功能正常,54%存在晚期钆增强和/或缺血,其中心肌炎样瘢痕26%、梗死和/或缺血22%、双重病理6%。弥漫性纤维化或水肿未见。

要点

  • 重症COVID-19康复者心肌炎样损伤范围局限,左室功能多正常。
  • 约四分之一患者存在缺血性心脏病,其中三分之二无既往冠心病史。
  • 恢复期CMR未检出弥漫性心肌纤维化或水肿。

核心结论

  • 重症COVID-19伴肌钙蛋白升高的康复期患者中,可见范围局限、功能影响轻微的心肌炎样损伤,部分存在持续局部炎症证据。
  • 约四分之一患者存在缺血性心脏病,其中三分之二无既往病史,是否为既往沉默病变或COVID-19相关新发改变尚不确定。
  • 未检测到弥漫性水肿或纤维化。

研究设计与样本

  • 研究纳入148例重症COVID-19住院且肌钙蛋白升高的康复患者,来自六家医院,年龄64±12岁,70%男性,48例(32%)需通气支持。
  • 患者在出院后中位68天接受恢复期多参数心脏磁共振检查,包括必要时腺苷负荷灌注。

主要发现

  • 左室功能正常者占89%,射血分数67%±11%。
  • 晚期钆增强和/或缺血见于54%(80/148),中心肌炎样瘢痕26%(39/148)、梗死和/或缺血22%(32/148)、双重病理6%(9/148)。
  • 心肌炎样损伤在88%(35/40)病例中局限于三个或更少心肌节段,且无相关左室功能障碍;其中30%存在活动性心肌炎。
  • 心肌梗死见于19%(28/148),负荷灌注者中可诱导缺血26%(20/76),包括7例同时有梗死和缺血。
  • 缺血性损伤模式患者中66%(27/41)无既往冠心病史;远端心肌T1 COVID-19患者1033±41 ms vs 匹配对照1028±35 ms,T2 COVID-19 46±3 ms vs 匹配对照47±3 ms。

临床怎么用

  • 对重症COVID-19伴肌钙蛋白升高的康复患者,可考虑CMR评估心肌损伤模式及缺血负荷。
  • 心肌炎样损伤多局限且功能影响小,但需注意部分存在活动性炎症。
  • 无冠心病史者仍可能检出缺血性心脏病,应结合临床评估冠状动脉疾病风险。

局限性

  • 研究为观察性设计,无法确定CMR所见为既往存在还是COVID-19相关新发改变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Troponin elevation is common in hospitalized COVID-19 patients, but underlying aetiologies are ill-defined. We used multi-parametric cardiovascular magnetic resonance (CMR) to assess myocardial injury in recovered COVID-19 patients. METHODS AND RESULTS: One hundred and forty-eight patients (64 ± 12 years, 70% male) with severe COVID-19 infection [all requiring hospital admission, 48 (32%) requiring ventilatory support] and troponin elevation discharged from six hospitals underwent convalescent CMR (including adenosine stress perfusion if indicated) at median 68 days. Left ventricular (LV) function was normal in 89% (ejection fraction 67% ± 11%). Late gadolinium enhancement and/or ischaemia was found in 54% (80/148). This comprised myocarditis-like scar in 26% (39/148), infarction and/or ischaemia in 22% (32/148) and dual pathology in 6% (9/148). Myocarditis-like injury was limited to three or less myocardial segments in 88% (35/40) of cases with no associated LV dysfunction; of these, 30% had active myocarditis. Myocardial infarction was found in 19% (28/148) and inducible ischaemia in 26% (20/76) of those undergoing stress perfusion (including 7 with both infarction and ischaemia). Of patients with ischaemic injury pattern, 66% (27/41) had no past history of coronary disease. There was no evidence of diffuse fibrosis or oedema in the remote myocardium (T1: COVID-19 patients 1033 ± 41 ms vs. matched controls 1028 ± 35 ms; T2: COVID-19 46 ± 3 ms vs. matched controls 47 ± 3 ms). CONCLUSIONS: During convalescence after severe COVID-19 infection with troponin elevation, myocarditis-like injury can be encountered, with limited extent and minimal functional consequence. In a proportion of patients, there is evidence of possible ongoing localized inflammation. A quarter of patients had ischaemic heart disease, of which two-thirds had no previous history. Whether these observed findings represent pre-existing clinically silent disease or de novo COVID-19-related changes remain undetermined. Diffuse oedema or fibrosis was not detected.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Kotecha T, Knight DS, Razvi Y, et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J. 2021. PMID: 33596594. doi:10.1093/eurheartj/ehab075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。